XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.20.2

Other (Income) Expense, Net | 6 Months Ended
--- | ---
Jun. 30, 2020
Other Income and Expenses [Abstract] |
Other (Income) Expense, Net | Other (Income) Expense, Net Other (income) expense, net, consisted of:
| Three Months Ended June 30, |  | Six Months Ended June 30,
($ in millions) | 2020 |  | 2019 |  | 2020 |  | 2019
Interest income | $ | (14 | ) |  | $ | (75 | ) |  | $ | (39 | ) |  | $ | (164 | )
Interest expense | 209 |  |  | 233 |  |  | 421 |  |  | 442 |
Exchange losses | 24 |  |  | 27 |  |  | 78 |  |  | 128 |
Income from investments in equity securities, net (1) | (551 | ) |  | (58 | ) |  | (603 | ) |  | (32 | )
Net periodic defined benefit plan (credit) cost other than service cost | (80 | ) |  | (140 | ) |  | (170 | ) |  | (281 | )
Other, net | 22 |  |  | 153 |  |  | (5 | ) |  | 234 |
| $ | (390 | ) |  | $ | 140 |  |  | $ | (318 | ) |  | $ | 327 |
(1) | Includes net realized and unrealized gains and losses from investments in equity securities either owned directly or through ownership interests in investment funds. Unrealized gains and losses from investments that are directly owned are determined at the end of the reporting period, while ownership interests in investment funds are accounted for on a one quarter lag. The Company estimates that gains of approximately $300 million will be recognized in the third quarter of 2020 from ownership interests in investment funds.
The decline in interest income in the second quarter and first six months of 2020 reflects lower investments and lower interest rates. The lower exchange losses in the first six months of 2020 reflect losses on forward exchange contracts in 2019 related to the acquisition of Antelliq. The increase in income from investments in equity securities, net, in both the second quarter and first six months of 2020 was driven primarily by the recognition of unrealized gains on certain investments, most of which relate to Moderna, Inc., as well as NGM Biopharmaceuticals, Inc. Other, net (as reflected in the table above) in the second quarter and first six months of 2019 includes $78 million and $162 million, respectively, of goodwill impairment charges related to certain businesses in the Healthcare Services segment. Interest paid for the six months ended June 30, 2020 and 2019 was $387 million and $356 million, respectively.

X
- References No definition available. + Details
Name: | us-gaap_OtherIncomeAndExpensesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 720 -URI http://asc.fasb.org/topic&trid=2122503 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 610 -URI http://asc.fasb.org/topic&trid=49130413 + Details
Name: | us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration